Discontinued — last reported Q2 '23
Sachem Capital Corp. CapEx decreased by 98.4% to $11.60K in Q2 2023 compared to the prior quarter. Year-over-year, this metric declined by 98.6%, from $811.68K to $11.60K.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $740.60K | $41.32K | $4.54K | $3.66K | $811.68K | $476.82K | $289.19K | $710.88K | $11.60K |
| QoQ Change | — | -94.4% | -89.0% | -19.4% | >999% | -41.3% | -39.4% | +145.8% | -98.4% |
| YoY Change | — | — | — | — | +9.6% | >999% | >999% | >999% | -98.6% |